524412 — Aarey Drugs and Pharmaceuticals Share Price
Last Trade - 00:00- IN₹886.28m
- IN₹1.01bn
- IN₹3.48bn
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Mar | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 3,959.67 | 3,493.48 | 3,547.41 | 3,000.89 | 3,484.16 | n/a | n/a | 7.21% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +288.02 | -12.72 | +5.9 | -11.44 | +12.61 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aarey Drugs & Pharmaceuticals Limited is engaged in active pharmaceutical ingredient (API)/Bulk Drugs manufacturing and offers a range of products for various industrial applications. The Company is engaged in trading and manufacturing activities. The Company is a manufacturer and supplier of pharmaceutical raw materials, chemicals, pharmaceutical ingredients, API's drugs, food colors and flavors. The Company's assortment of pharmaceutical products includes Metronidazole and Metronidazole Benzoate. Its products include Monomethyl Urea (MMU, Dimethyl Urea (DMU), Theobromine (THB), Theophylline (THP) and Pentoxifylline (PTF). Its other businesses include aromatics chemical, chemical acid, chlor alkalis, industrial alcohols, industrial ketones, glycols and glycol ethers, fiber intermediates, industrial amines, acetates and esters, chlorinated solvents, industrial intermediates and industrial chemicals.
Directors
- Mihir Ghatalia CHM
- Mira Ghatalia
- Preeti Rathi
- Damiyanti Ghatalia
- Nimit Ghatalia
- Anil Mandal DRC
- Chetan Mehta (44)
- Lalit Tulsiani NID (57)
- Last Annual
- March 31st, 2021
- Last Interim
- March 31st, 2021
- Incorporated
- May 15th, 1990
- Public Since
- December 8th, 1993
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 23,384,684
- Address
- 107, Sahakar Bhavan, MUMBAI, 400009
- Web
- http://www.aareydrugs.com/
- Phone
- +91 2266312997
- Auditors
- DMKH & CO.
Upcoming events for 524412
Similar to 524412
ANG LIFESCIENCES INDIA ORD
Bombay Stock Exchange
AURO LABORATORIES ORD B
Bombay Stock Exchange
BACIL PHARMA ORD T
Bombay Stock Exchange
BAJAJ HEALTHCARE ORD M
Bombay Stock Exchange
BERYL DRUGS ORD T
Bombay Stock Exchange
FAQ
As of Today at 11:31 UTC, shares in Aarey Drugs and Pharmaceuticals are trading at IN₹37.95. This share price information is delayed by 15 minutes.
Shares in Aarey Drugs and Pharmaceuticals last closed at IN₹37.95 and the price had moved by +58.13% over the past 365 days. In terms of relative price strength the Aarey Drugs and Pharmaceuticals share price has outperformed the S&P BSE 100 Index by +8.59% over the past year.
There is no consensus recommendation for this security.
Aarey Drugs and Pharmaceuticals does not currently pay a dividend.
Aarey Drugs and Pharmaceuticals does not currently pay a dividend.
Aarey Drugs and Pharmaceuticals does not currently pay a dividend.
To buy shares in Aarey Drugs and Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹37.95, shares in Aarey Drugs and Pharmaceuticals had a market capitalisation of IN₹886.28m.
Here are the trading details for Aarey Drugs and Pharmaceuticals:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 524412
Based on an overall assessment of its quality, value and momentum Aarey Drugs and Pharmaceuticals is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aarey Drugs and Pharmaceuticals. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +25.53%.
As of the last closing price of IN₹37.95, shares in Aarey Drugs and Pharmaceuticals were trading +25.74% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Aarey Drugs and Pharmaceuticals.
Aarey Drugs and Pharmaceuticals' management team is headed by:
- Mihir Ghatalia - CHM
- Mira Ghatalia -
- Preeti Rathi -
- Damiyanti Ghatalia -
- Nimit Ghatalia -
- Anil Mandal - DRC
- Chetan Mehta -
- Lalit Tulsiani - NID
We do not have data on Aarey Drugs and Pharmaceuticals' shareholders